Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Son-D-Farms Inc
WARNING LETTER
•Son-D-Farms Inc•September 16, 2011

FDA WARNING_LETTER - Son-D-Farms Inc - September 16, 2011

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

On September 14 and 16, 2011, the FDA inspected Son-D-Farms Inc.'s swine operation in Adrian, Minnesota, identifying significant violations of the Federal Food, Drug, and Cosmetic Act. The primary finding was the sale of an adulterated sow for slaughter, which contained penicillin residues (0.68 ppm in kidney) exceeding the zero tolerance (21 CFR 556.510), a violation of 21 U.S.C. § 342(a)(2)(C)(ii). The investigation also revealed that animals were held under inadequate conditions, such as failing to segregate treated animals and maintain complete treatment records, increasing the likelihood of medicated animals with harmful residues entering the food supply, thus adulterating food under 21 U.S.C. § 342(a)(4). Furthermore, the firm engaged in extralabel use of penicillin G procaine injectable suspension, administering an incorrect dosage (2 cc per 100 pounds instead of 1 mL per 100 pounds) without a prescription or a valid veterinary-client-patient relationship. This constituted a violation of 21 CFR 530.11(a) and resulted in illegal drug residues, violating 21 CFR 530.11(d). Consequently, the drug itself was deemed unsafe and adulterated under 21 U.S.C. § 360b(a) and 21 U.S.C. § 351(a)(5). Son-D-Farms Inc. is required to take prompt corrective actions within 15 working days, detailing steps to prevent recurrence, or face potential regulatory actions like seizure or injunction.

Company
Son-D-Farms Inc
Inspection Date
September 16, 2011
Product Type
Drugs
Office
Department of Health and Human Services
Person
  • Gerald J. Berg
Open in Dashboard

ID · 59112ce9-a9f2-4492-9dd0-25352effd6c3

Violation Codes10
21 U.S.C. 342(a)(2)(C)(ii)21 U.S.C. 360b21 U.S.C. 342(a)(4)21 CFR 556.51021 CFR 530.3(a)21 U.S.C. 360b(a)(4)21 U.S.C. 360b(a)(5)21 CFR 53021 CFR 530.11(a)21 CFR 530.11(d)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.